Consultation

Proposal To Fund An Additional Brand Of Budesonide With Eformoterol Dry Powder Inhaler

NZNO warmly invites your feedback on PHARMAC’s proposal to fund an additional brand (DuoResp Spiromax) of two of the three funded strengths of budesonide with eformoterol dry powder inhaler from 1 October 2020 through a provisional agreement with Teva Pharmaceuticals Ltd ("Teva").

Further information can be seen here.

Please note the short consultation timeframe.

If the Policy Team receives no feedback, NZNO will not make a submission.

Please send feedback to PolicyAnalysts@nzno.org.nz by 10 August 2020.

Posted in: Consultations

Revocation and Replacement of the Health Information Privacy Code under the Privacy Act 2020

NZNO welcome your feedback on proposed changes made to the Health Information Privacy Code. The changes are not intended to enact policy changes, aside from those implemented in the Privacy Act 2020.

The key updates to this code which may be relevant to nurses are:

  • If the lawful purpose for which health information about an individual is collected does not require the collection of an individual’s identifying information, the health agency may not require the individual’s identifying information.
  • A new exception to allow collection from a source other than the individual where necessary to prevent or lessen a serious threat to the life or health of the individual concerned or any other individual
  • A new information privacy principle relating to crossborder disclosures and other substantive and technical amendments made to the information privacy principles in the new Act;
  • Updating clause numbering where previous amendments to the 1994 code has led to such numbering being out of sequence;
  • Removal of section notes and square brackets relating to previous amendments;
  • Decapitalisation of some words, such as “code of practice” and “rule”.

The proposed code broadly has retained the ordering of subrules in the 1994 code, including where that order differs from the information privacy principles in the Act.

The information paper can be found here.

A copy of the proposed code, which sets out the changes in bold and with commentary can be found here.

Please send feedback to PolicyAnalysts@nzno.org.nz by 7 August 2020.

Posted in: Consultations

Worksafe proposed changes to the Workplace Exposure Standards (WES) of 18 substances and the Biological Exposure Indices (BEI) of 4 substances

NZNO welcomes your feedback on proposed changes to the Workplace Exposure Standards (WES) of 18 substances and the Biological Exposure Indices (BEI) of 4 substances.  

WES and BEI are important tools for monitoring worker’s biological and airborne exposure. WES are values that refer to the airborne concentration of substances. BEI are guidance values for assessing biological monitoring results which measures the concentration of a substance – or its breakdown products - in blood or urine or even exhaled air. The monitoring result is compared to the BEI established for the specific substance.

18 substances of WES:

  1. Acetaldehyde
  2. Allyl glycidyl ether
  3. Aniline and homologues
  4. Arsenic
  5. Benzene
  6. Cadmium and cadmium compounds
  7. Chromium compounds
  8. Copper
  9. Diethyl sulphate
  10. 4,6-Dinotro-o-cresol
  11. 1,4 Dioxane
  12. Formaldehyde
  13. Hydroquinone
  14. Phenol
  15. Synthetic mineral fibres
  16. Vanadium
  17. Vinyl Acetate
  18. Zinc Oxide

4 substances of BEI:

  1. Arsenic
  2. Benzene
  3. Cadmium and cadmium compounds
  4. Phenol

Please find further consultation information here.

Further information on WES, including the meaning of WES-TWA and WES-STEL, and BEI is provided in the Glossary sections of the relevant proposal documents.

Please send feedback to PolicyAnalysts@nzno.org.nz by 14 August 2020.

Posted in: Consultations

Proposed Guidelines for the Posthumous Use of Gametes, Reproductive Tissue and Stored Embryos

NZNO warmly invites your feedback on draft guidelines for the use of gametes and reproductive tissue from deceased people and already stored embryos from the now deceased. These guidelines are proposed to replace Guidelines for the Storage, Use, and Disposal of Sperm from a Deceased Man (released in 2000).

Feedback from a 2018 public consultation (Phase One) has informed the development of the new document. It incorporates technical and sociological changes, including taking into account stored embryos, reproductive tissue (from ovaries and testes) and all gametes.

The draft guidelines are attached for your review. You are welcome to provide your feedback in an email or use ACART’s feedback form (also attached) to send us your feedback. We will incorporate your feedback into the NZNO response. 

Please send feedback to PolicyAnalysts@nzno.org.nz by 2 September 2020.

Posted in: Consultations

Proposal To List Medical Devices Supplied By Obex Medical Ltd

NZNO warmly invites your feedback on PHARMAC’s proposal to list 422 medical devices supplied by Obex Medical Ltd in the  following categories:

  • surgical suction, chest and wound drainage; and
  • obstetrics and gynaecology.

Further information, including the list of products can be seen here.

Please note the short consultation timeframe.

If the Policy Team receives no feedback, NZNO will not make a submission.

Please send feedback to PolicyAnalysts@nzno.org.nz by 28 July 2020.

Posted in: Consultations

Proposal To Modify Pharmac's Approach To Competitive Procurement

NZNO warmly invites your feedback on PHARMAC’s proposal to standardize the way they contract for pharmaceuticals. They aim to create a consistent approach between the community and DHB hospital markets and to improve on the methods that have been used for many years.

Further information is available here on the PHARMAC website.

Please note the short consultation period.

Please send feedback to PolicyAnalysts@nzno.org.nz by Tuesday 21 July 2020.

 

Posted in: Consultations

Feedback is sought on the draft “New Zealand COPD Guidelines Quick Reference Guide”.

NZNO welcomes your feedback on a draft quick reference guide that aims to provide simple, practical, evidence-based recommendations for the diagnosis, assessment and management of Chronic Obstructive Pulmonary Disease (COPD) in clinical practice. 

The consultation document is below. It provides questions to guide your feedback.

Please send feedback to PolicyAnalysts@nzno.org.nz by 27 July 2020.

Posted in: Consultations

Proposal to List Medical Devices Supplied By Lohmann & Rauscher Ltd

NZNO warmly invites your feedback on PHARMAC’s proposal to list a range of medical devices supplied by Lohmann & Rauscher. The proposal is for eleven products in the following categories:

  • Rehabilitation Equipment, Patient Positioning Products and Supports (Cellona Shoe); and
  • Non-Dedicated & Consumable Infusion Devices (Curafix i.v., Curagard).

Further information, including the list of products can be seen here.

Please send feedback to PolicyAnalysts@nzno.org.nz by 23 August 2020.

Posted in: Consultations

Sex and Gender Identity Statistical Standards; Consultation

NZNO invites your feedback on proposed changes to the way sex and gender data are collected in New Zealand.

Stats NZ proposes changes that aim to be more inclusive, particularly of transgender and intersex people, by recording and presenting information on sex and gender that is accurate, respects individual human rights and better meets information needs.

The statistical standards are important because they provide guidance for people and organisations on how to collect and use sex and gender data.

Please find further consultation information here.

Please send feedback to PolicyAnalysts@nzno.org.nz by 6 August 2020.

Posted in: Consultations

Proposal to List New Rehabilitation Products

NZNO invites your feedback on PHARMAC’s proposal to list rehabilitation equipment, patient positioning products and supports supplied by At Therapy Limited and Morton & Perry Limited in Part III of Section H of the Pharmaceutical Schedule from 1 September 2020.

Under the proposal, the suppliers above would be listed under proposed national agreements for all DHB hospitals to purchase under. The proposal would result in listing 1,228 products in the Pharmaceutical Schedule. DHBs could continue to purchase other suppliers’ brands of Rehabilitation Products.

Please find further consultation information here

Please send feedback to PolicyAnalysts@nzno.org.nz by Wednesday 8 July 2020.

Posted in: Consultations

National Contraception Guidelines

NZNO invites your feedback on the Ministry of Health’s national guidance on contraception. The Guidelines, and associated training, aim to :

  • increase access to effective contraception options for New Zealanders
  • support informed choice
  • increase uptake of long-acting reversible contraception, and
  • support health practitioners to have consistent, culturally safe and youth friendly conversations on sexual health and contraception.

The draft guidance is based on a range of existing guidelines, literature reviews, and the views of the National Contraception Guidelines Steering Group.

Please see plan below

Please send feedback to PolicyAnalysts@nzno.org.nz by Monday 13 July 2020.

 

Read or Download
Posted in: Consultations

Draft Ethical Framework for Resource Allocation in Times of Scarcity

NZNO welcomes your feedback on this draft document which provides ethical values to guide actions during a pandemic. This Framework is part of the NEAC planned review of their 2007 document 'Getting Through Together: Ethical Values for a Pandemic'.

The Framework is a high-level guidance document that helps health workers and policy makers consider ethics when allocating resources for COVID-19. It also aims to help decision-makers to identify the ethical tensions and recommends the establishment of decision-making groups to work through the tensions and uphold transparency of decisions.

The framework includes Te Tiriti principles and equity as a core principle. It sets out four essential ethical principles and four Te Tiriti principles that medical staff, service planners and policy analysts should consider when responding to pandemics.  Equity as a concept recognises different people have different levels of advantage, therefore require different approaches and resources to get equitable health outcomes.

There is an optional question in this consultation that asks for your views on what ethical issues should be covered in the update.

Final draft NEAC framework:

https://consult.health.govt.nz/neac/resource-allocation-ethics/supporting_documents/NEAC%20Framework%20for%20Resource%20Allocation%20final%20draft.docx

Please send feedback to Leanne.rahman@nzno.org.nz by 3 July 2020.

Read or Download
Posted in: Consultations

Kia Kaha, Kia Māia, Kia Ora Aotearoa - COVID-19 Psychosocial and Mental Wellbeing Recovery Plan

NZNO warmly welcomes your feedback on this plan which provides a national approach to supporting the mental and social wellbeing of New Zealanders in the COVID-19 recovery period. This plan provides a framework for collective actions to support whānau and communities to adapt and thrive in the next 12 to 18 months. It draws on the directions for mental wellbeing that were laid down in He Ara Oranga: Report of the Government Inquiry into Mental Health and Addiction. Your input will help build a collective picture of how the nursing workforce is contributing to COVID-19 recovery and will assist with shaping a further iteration of the plan, anticipated for September 2020. 

Please see the plan below.

Please consider the following questions:

  1. Do the vision, principles and focus areas in the plan resonate with you? 
  2. In what ways does your organisation see itself contributing to the focus areas in the plan?
  3. What do you think the critical factors to ensure success of this plan?
  4. What positive examples of actions to support mental and social wellbeing are you aware of?

Do you think there is anything missing from the plan?

Please send feedback to  PolicyAnalysts@nzno.org.nz by 8 June 2020.

Read or Download
Posted in: Consultations

12345678910Last

Notify me when this page changes

Enter your email address below to receive alerts when this page is updated.

Sign up below to receive an email when we update this page

Email:  
Captcha:
CAPTCHA image
Enter the code shown above in the box below.